.png)
The unique blend of experienced physicians and researchers makes the management very strong and uniquely aligned towards our vision of developing natural products for difficult to treat disorders. The team has solid core understanding and values of science and technology, applying modern medicine and biotechnology testing tools to ancient sciences. Unique research capabilities allow the company to be flexible and adapt to the ever-changing nutraceutical and phyto-pharmaceutical markets and to stringent regulatory requirements.
.svg)
.svg)
The human race evolved phenomenally over the last few thousand years. Medical science also progressed substantially, with newer chemicals and technologies to address most of the common ailments. But, in more recent times, modern medicine has met with significant challenges in the cost of development of new molecules, limitations of therapy and significant side effects.
We take the fundamental knowledge of Ayurveda, utilize an accelerated screening methodology, and establish very rapidly the specific plants to be targeted. This gives the Company tremendous confidence in choosing the right plant/s and a significant leap in the discovery process. Further, since the safety parameters are already established, both over centuries of use and documentation, our scientists can develop parallel (not sequential) activities to establish safety and efficacy in the identified phyto-pharmaceutical. Using Bioved's proprietary N/Rx® Platform, full validation is conducted to establish the safety and efficacy in chemistry, standardization, in-vitro cell line studies for efficacy and safety, along with in-vivo pharmacology and toxicology, and human clinical trials.
(The Knowledge of Life) comes from one of the most advanced civilizations of the ancient world, India. Detailed text books, written as early as 4,500 years ago, give amazing information on medical conditions and offer a whole range of therapies, for a wide variety of diseases, with the help of an impressive armament of medicinal plants and minerals. Considerable work has been done over the centuries in this science to define the specific therapies for specific diseases, as described in modern medicine. Ayurveda describes in detail the medicinal values of various plants, herbs and trees. But the non-standard nature of the ancient knowledge makes it difficult for modern medicine to prepare a universal solution.
Bioved is dedicated to deciphering this ancient knowledge using modern medical technologies; and developing solutions that are validated to prescription levels. Through our research and understanding, we are committed to improving human health and Quality of Life, especially in the aging population.
Beyond business success, we believe in giving back to society. Year X marked the initiation of our corporate social responsibility programs,
Innovation has been the driving force behind our progress. Year H witnessed the launch of groundbreaking products or the implementation of revolutionary technologies that set new industry standards.
With an unwavering commitment to our mission and an ever-evolving vision, we are excited about what the future holds. As we move forward,
There are over a hundred chemical substances that have been derived from plants for use as drugs and medicines. Drugs such as digitalis for cardiac disorders, atropine an anti-cholinergic, reserpine for high blood pressure, vincristine, vinblastine and paclitaxel for chemotherapy; and numerous other modern pharmaceuticals have their origin from plants. Bioved technology is to keep the plant or its medicinal part in natural form, isolate the bio-active fraction by a US patented and proprietary method, and then complete the full spectrum of testing at world class standards. This ensures novel and unique ‘composition of matter’ with characterization of the component molecules; and scientific validation to create solutions that meet the needs of a global population.
%201.png)
Bioved is led by a team of committed doctors and medical scientists who have worked since early nineties diligently to invent unique extraction methods, prepare effective dosages, conducted tests and trials to make Bioved a distinctively different pharmaceutical company with an enviable portfolio of patents.
Dr. Chitre is the Founder of Bioved Pharmaceuticals, Inc. She received medical degrees from UC San Francisco and Grant Medical College. Subsequently, Dr Chitre was on the faculty at Stanford University for 10 ½ years. A personal experience led her to the founding of Bioved and to the development of the Discovery Platform for natural plant-based, scientifically validated, human and animal nutraceuticals and phyto-pharmaceuticals. Dr Chitre has several publications and US patents issued, and drives the expansion of Bioved Human and Animal Health in multiple continents of the world.
He has 30 years in animal health including veterinary practice, academics, distribution, new company launches, generic pharmaceutical and supplement manufacturing. He has certifications in medical cannabis and a bachelor’s degree in Natural Science with minors in Chemistry and Biology. He co-founded Quincy Animal Health (Neutricks®), a product for cognitive dysfunction in pets.
Dr. Mattu is passionate about making a positive impact on the lives of pets and people. He owned University Veterinary Hospital, was President of Veterinary Passions Associates, and was COO for Vets Beyond Medicine. He received his DVM from Iowa State Uni. and Punjab Ag Uni, followed by an MBA from UC Berkeley, Haas School of Business.
Experienced Principal and entrepreneur with a demonstrated history of building businesses supporting public and private sectors. He has an MS from Clemson University and an MBA from University of Southern California - Marshall School of Business.
Dr. Dey has multiple US, and Intl’ patents issued/applied, and over 60 publications in Drug Discovery and Research; and has received national and international Awards for ‘Scientific Excellence.” With a PhD in Biochemistry, he was on the Faculty at UC Davis. He was the Founder Scientist at Calyx Therapeutics and VP Research at Bexel Pharmaceuticals. Dr Dey has raised funding in Series A, B and C rounds; ran drug discovery research, and built scientific liaisons with pharma companies, academic institutions, and the NIH.
Mr Grigsby is a graduate of University of California, Berkeley where he was a star basketball player. He played professionally in Japan & Europe. On returning from basketball, he joined a topical analgesic company, Flex Power in California as VP Business Development. He has been with Bioved for more than 10 years and oversees the sales and marketing division of the company. He has been implemental in exponential sales growth through orthopedists, chiropractors, physical therapists, and distributors.
Mr. Chitre has been a Director of the Indian subsidiary since its inception. A graduate from the University of Pune, he started his career in medical sales as a very early team member of Lupin Ltd., now one of the top 5 pharmaceutical companies in India. Subsequently he had a successful distribution company of specialty consumer goods with distribution and network all over the sub-continent. He manages the day to day operations of Bioved India.
.png)
